Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	519.85	615.1	905.45	1,431	1,895
Short-Term Investments	6.14	13.41	2.09	65.63	367.39
Cash & Short-Term Investments	525.99	628.5	907.55	1,497	2,263
Cash Growth	-16.31%	-30.75%	-39.37%	-33.84%	450.69%
Accounts Receivable	165.87	149.61	151.71	134.59	110.75
Other Receivables	0.18	1.18	0.1	0.11	2.23
Receivables	166.05	150.79	151.81	138.2	112.98
Inventory	62.63	69.02	130.32	123.21	68.02
Restricted Cash	2.31	0.12	19.82	7.8	29.9
Other Current Assets	19.65	35.67	49.27	54.79	50.06
Total Current Assets	776.62	884.1	1,259	1,821	2,524
Property, Plant & Equipment	100.34	144.2	300.03	406.45	111.48
Long-Term Investments	-	0.34	0.69	0.91	1.42
Other Intangible Assets	0.42	0.96	1.99	5.15	3.46
Other Long-Term Assets	7.93	5.09	20.89	45.14	23.02
Total Assets	885.31	1,040	1,587	2,279	2,663
Accounts Payable	33.75	18.06	50.95	63.08	35.48
Accrued Expenses	56.94	65.37	104.23	107.03	71.89
Short-Term Debt	-	-	-	2.37	7.37
Current Portion of Long-Term Debt	-	-	-	-	34.7
Current Portion of Leases	24.57	8.63	37.24	35	4.82
Current Income Taxes Payable	14.46	20.62	11.03	7.69	6.99
Current Unearned Revenue	117.9	130.54	147.63	142.87	74.4
Other Current Liabilities	18.69	20.14	60.38	14.14	5.89
Total Current Liabilities	266.3	263.36	411.45	372.18	241.53
Long-Term Leases	27.75	3.69	13.55	49.32	-
Long-Term Unearned Revenue	-	-	-	-	0.26
Other Long-Term Liabilities	10.43	4.54	4.12	11.78	0.23
Total Liabilities	304.48	271.59	429.13	433.28	242.02
Common Stock	0.15	0.14	0.14	0.14	0.14
Additional Paid-In Capital	5,002	4,849	4,583	4,281	4,007
Retained Earnings	-4,200	-3,854	-3,200	-2,229	-1,418
Treasury Stock	-63.26	-65.9	-58.92	-	-
Comprehensive Income & Other	-158.05	-161.53	-165.72	-207.07	-167.59
Total Common Equity	580.83	768.41	1,158	1,845	2,421
Shareholders' Equity	580.83	768.41	1,158	1,845	2,421
Total Liabilities & Equity	885.31	1,040	1,587	2,279	2,663
Total Debt	52.32	12.32	50.79	86.69	46.88
Net Cash (Debt)	473.66	616.18	856.76	1,410	2,216
Net Cash Growth	-23.13%	-28.08%	-39.25%	-36.35%	545.24%
Net Cash Per Share	46.02	60.18	82.45	135.33	322.84
Filing Date Shares Outstanding	10.77	10.26	10.27	10.52	10.45
Total Common Shares Outstanding	10.76	10.24	10.26	10.51	10.48
Working Capital	510.32	620.73	847.31	1,449	2,282
Book Value Per Share	53.97	75.01	112.85	175.56	231.05
Tangible Book Value	580.41	767.45	1,156	1,840	2,418
Tangible Book Value Per Share	53.93	74.92	112.66	175.07	230.72
Machinery	307.49	348.07	339.09	297.89	180.54
Construction In Progress	0.63	0.55	2.66	27.56	1.09
Leasehold Improvements	187.23	187.39	187.38	161.04	30.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q